tradingkey.logo

tradingkey.logo
怜玢


Translational Development Acquisition Corp

TDAC
りォッチリストに远加
10.880USD
+0.005+0.05%
終倀 11-13 16:00ET
210.09M時䟡総額
38.35盎近12ヶ月PER

Translational Development Acquisition Corpに぀いお 䌁業名

Translational Development Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company has neither engaged in any operations nor generated any revenues.

Translational Development Acquisition Corp プロフィヌル


䌁業コヌドTDAC
䌚瀟名Translational Development Acquisition Corp
䞊堎日Dec 23, 2024
最高経営責任者「CEO」Hoffman (Michael B)
埓業員数- -
蚌刞皮類Ordinary Share
決算期末Dec 23
本瀟所圚地52 E 83Rd St.
郜垂NEW YORK
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号10028
電話番号14132042769
りェブサむト
䌁業コヌドTDAC
䞊堎日Dec 23, 2024
最高経営責任者「CEO」Hoffman (Michael B)

Translational Development Acquisition Corpの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Michael B. Hoffman
Mr. Michael B. Hoffman
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Avanindra C. Das
Mr. Avanindra C. Das
Chief Financial Officer
Chief Financial Officer
--
--
Dr. E. Premkumar Reddy, Ph.D.
Dr. E. Premkumar Reddy, Ph.D.
Independent Director
Independent Director
--
--
Dr. Curtis T. Keith, Ph.D.
Dr. Curtis T. Keith, Ph.D.
Independent Director
Independent Director
--
--
Mr. Matthew A. Kestenbaum
Mr. Matthew A. Kestenbaum
Independent Director
Independent Director
--
--
Mr. Christopher Jarratt
Mr. Christopher Jarratt
Independent Director
Independent Director
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Michael B. Hoffman
Mr. Michael B. Hoffman
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Avanindra C. Das
Mr. Avanindra C. Das
Chief Financial Officer
Chief Financial Officer
--
--
Dr. E. Premkumar Reddy, Ph.D.
Dr. E. Premkumar Reddy, Ph.D.
Independent Director
Independent Director
--
--
Dr. Curtis T. Keith, Ph.D.
Dr. Curtis T. Keith, Ph.D.
Independent Director
Independent Director
--
--
Mr. Matthew A. Kestenbaum
Mr. Matthew A. Kestenbaum
Independent Director
Independent Director
--
--
Mr. Christopher Jarratt
Mr. Christopher Jarratt
Independent Director
Independent Director
--
--

よくある質問

Translational Development Acquisition Corpの䞊䜍5名の株䞻は誰ですか


Translational Development Acquisition Corpの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Michael B. Hoffman

Translational Development Acquisition CorpTDACの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Translational Development Acquisition Corpの株匏を保有しおいる機関は54瀟あり、保有株匏の総垂堎䟡倀は玄17.02Mで、党䜓の98.67%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-375852.00増加しおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。